NGM Biopharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACHL
Achilles Therapeutics plc |
$1.17 | $37.06 M | -0.56 | 204 | $0 |
ASMB
Assembly Biosciences, Inc. |
$14.60 | $78.73 M | -1.35 | 65 | $7.16 M |
CCCC
C4 Therapeutics, Inc. |
$3.75 | $320.64 M | -1.97 | 145 | $20.76 M |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
ERAS
Erasca, Inc. |
$1.92 | $647.94 M | -2.83 | 126 | $0 |
FHTX
Foghorn Therapeutics Inc. |
$4.26 | $332.53 M | -2.73 | 116 | $34.16 M |
GBIO
Generation Bio Co. |
$0.89 | $216.88 M | -1.28 | 174 | $5.90 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.55 | $243.38 M | -1.59 | 133 | $0 |
IPSC
Century Therapeutics, Inc. |
$0.92 | $244.54 M | -1.32 | 152 | $2.24 M |
KROS
Keros Therapeutics, Inc. |
$12.48 | $1.76 B | -9.45 | 160 | $151,000 |
KZR
Kezar Life Sciences, Inc. |
$6.22 | $49.85 M | -0.49 | 58 | $7.00 M |
LYEL
Lyell Immunopharma, Inc. |
$0.58 | $619.50 M | -2.7 | 224 | $130,000 |
MLYS
Mineralys Therapeutics, Inc. |
$9.09 | $652.38 M | -6.03 | 28 | $0 |
NKTX
Nkarta, Inc. |
$2.22 | $465.09 M | -2.81 | 159 | $0 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
NXTC
NextCure, Inc. |
$0.79 | $38.88 M | -0.61 | 82 | $0 |
PRLD
Prelude Therapeutics Incorporated |
$1.01 | $205.99 M | -2.02 | 128 | $0 |
RZLT
Rezolute, Inc. |
$4.71 | $229.57 M | -5.02 | 59 | $0 |
SANA
Sana Biotechnology, Inc. |
$3.63 | $1.55 B | -4.59 | 328 | $0 |
TIL
Instil Bio, Inc. |
$20.19 | $69.59 M | -0.56 | 49 | $0 |